RNAZ NASDAQ · Healthcare · FY 2025-12-31

Transcode Therapeutics, Inc.

0.03.57.010.513.9ABVfair 12.91buy ≤ 3.23EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 4.56 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in USD
Verdict
Wait
Buy zone
Fair–Wait
Archetype
Distressed/Deficit
Confidence
●○○ Low · 1/4

Price
4.560 USD
Market cap
4.2M USD
P / B
0.03
P / E
EPS
-52.590
DPS / yield
(0.0%)
NAV / share
12.908
Graham number
Z'' score
12.52
Piotroski F
3 / 9
Beneish M
ROIC vs WACC
-23.4% vs 12.5%

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.